News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactLog in
Book a Demo
Foresight logo
All News & Insights

EU Grants Union Authorisation to ClearKlens Wipes

BPR
4
September 2024
•
420
Dr Steven Brennan
ClearKlens wipes have received EU approval for their effective disinfecting properties, ensuring compliance with safety standards across Europe.
ClearKlens wipes based on IPA
Quick prompts

AI Generated

Get to the point quicker with prompts - a smarter way to get the information you need from our articles.

Summarise this article

AI Assistant

This feature and much more is available on our platform. If you would like early access, please leave your email and we'll get in touch.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

ClearKlens wipes, a powerful biocidal product developed by Diversey Europe Operations B.V., have recently received Union authorisation for use across the European Union. This significant approval, granted under Commission Implementing Regulation (EU) 2024/2189, marks a milestone in the product's journey and reflects its compliance with stringent EU regulations concerning biocidal products.

What Are ClearKlens Wipes?

ClearKlens wipes are a biocidal product designed for disinfecting surfaces. They are based on isopropyl alcohol (IPA), a widely recognised active substance for its effectiveness in eliminating a broad spectrum of microorganisms, including bacteria and viruses. The product falls under product-type 2, which covers disinfectants and algaecides not intended for direct application to humans or animals, as described in Annex V of Regulation (EU) No 528/2012.

The Significance of Union Authorisation

The Union authorisation granted to ClearKlens wipes by the European Commission allows the product to be marketed and used throughout the EU without the need for separate national authorisations. This approval is valid from 24 September 2024 to 31 August 2034, providing a ten-year window during which the product can be freely distributed and utilised across all member states.

The process leading to this authorisation involved a rigorous evaluation by the European Chemicals Agency (ECHA) and the competent authority of the Netherlands. After a comprehensive assessment of its safety, efficacy, and compliance with EU standards, ClearKlens wipes were deemed to meet all the necessary requirements laid down in Article 19(1) of Regulation (EU) No 528/2012.

Why Choose ClearKlens Wipes?

  1. Effective Disinfection: ClearKlens wipes utilise propan-2-ol, a potent active ingredient that effectively destroys bacteria, viruses, and fungi, ensuring a high level of hygiene for various surfaces.
  2. Convenience and Safety: The wipes are designed for ease of use, providing a quick and effective method of disinfection without the need for additional equipment or protective measures. They are particularly useful in healthcare settings, food preparation areas, and other environments where stringent hygiene is paramount.
  3. Regulatory Compliance: With the recent EU authorisation, users can be confident that ClearKlens wipes meet all regulatory standards for safety and environmental impact, making them a reliable choice for public and professional use.
  4. Long Shelf Life: The authorisation until 2034 ensures that ClearKlens wipes will be available for the next decade, offering a stable and consistent supply for businesses and institutions.

The Path to Authorisation

The journey to obtaining Union authorisation for ClearKlens wipes began in March 2020 when Diversey Europe Operations B.V. submitted their application to ECHA. After thorough evaluation and review, including the submission of an assessment report and conclusions in July 2023, the final opinion and draft summary of product characteristics were provided by ECHA in December 2023. The Commission, agreeing with ECHA's assessment, granted the authorisation on 3 September 2024.

This process underscores the EU's commitment to ensuring that only products meeting high safety and efficacy standards are authorised for use, protecting both public health and the environment.

Conclusion

ClearKlens wipes represent a robust solution for disinfection needs across various sectors. The recent EU-wide authorisation not only facilitates its availability across all member states but also assures users of its compliance with stringent health and safety regulations. As the world continues to prioritise hygiene and safety, products like ClearKlens wipes play a crucial role in maintaining high standards of cleanliness and infection control.

With its Union authorisation now in place, ClearKlens wipes are set to become a staple in effective hygiene practices across the European Union.

Read the source story

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

Personal care productsECHA's Assessment Highlights Potential Risks of Quaternary Ammonium Compounds

January 30, 2025

Man with paperworkUK HSE Issues Notice on EU Biocides Regulation: Key Active Substances Face Non-Approval in Northern Ireland

January 30, 2025

Cleaner in a hospitalAssessment of Regulatory Neeeds for Long Chain Aliphatic Quaternary Ammonium Compounds

January 26, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

Personal care products

ECHA's Assessment Highlights Potential Risks of Quaternary Ammonium Compounds

ECHA's new assessment on quaternary ammonium compounds may have future impacts on disinfectants, pest control, and personal care products.

30

Jan 2025

CLP
REACH
BPR
Man with paperwork

UK HSE Issues Notice on EU Biocides Regulation: Key Active Substances Face Non-Approval in Northern Ireland

Discover the latest UK HSE notice on EU biocides regulation changes affecting Northern Ireland.

30

Jan 2025

BPR
Cleaner in a hospital

Assessment of Regulatory Neeeds for Long Chain Aliphatic Quaternary Ammonium Compounds

ECHA proposes new regulations for quaternary ammonium compounds to mitigate environmental and health risks.

26

Jan 2025

REACH
CLP
BPR
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Coverage
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy